Use of mucolytics and inhaled antibiotics in the NICU

Fahy JV, Dickey BF. Airway mucus function and dysfunction. N Engl J Med. 2010;363:2233–47.

Article  PubMed  PubMed Central  CAS  Google Scholar 

King M. Physiology of mucus clearance. Paediatr Respir Rev. 2006;7:S212–4.

Article  PubMed  Google Scholar 

Rogers DF. Overview of Airway Mucus Clearance. In: Rubin BK, van der Schans CP, eds. Therapy for Mucus-Clearance Disorders. Marcel Dekker: New York, NY, 2004, pp 1–27.

Ma J, Rubin BK, Voynow JA. Mucins, Mucus, and Goblet Cells. Chest. 2018;154:169–76.

Article  PubMed  Google Scholar 

King M. Mucolytics and Mucus Clearance. In: Rubin BK, van der Schans CP, editors. Therapy for Mucus-Clearance Disorders. Marcel Dekker: New York, NY, 2004, pp 201–24.

Rubin BK. Mucus and mucins. Otolaryngol Clin North Am. 2010;43:27–34.

Article  PubMed  Google Scholar 

Openshaw P, Edwards S, Helms P. Changes in rib cage geometry during childhood. Thorax. 1984;39:624–7.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Mortola JP. Chest wall mechanics in newborns. In: Roussos C, editor. The Thorax, 2 edn, vol. A. Dekker, M: New York, NY, 1995, pp 617–31.

Knill R, Andrews W, Bryan AC, Bryan MH. Respiratory load compensation in infants. J Appl Physiol. 1976;40:357–61.

Article  PubMed  CAS  Google Scholar 

Davi M, Sankaran K, Maccallum M, Cates D, Rigatto H. Effect of sleep state on chest distortion and on the ventilatory response to CO2 in neonates. Pediatr Res. 1979;13:982–6.

Article  PubMed  CAS  Google Scholar 

Papastamelos C, Panitch HB, England SE, Allen JL. Developmental changes in chest wall compliance in infancy and early childhood. J Appl Physiol. 1995;78:179–84.

Article  PubMed  CAS  Google Scholar 

Stocks JM, Hislop AA. Structure and function of the respiratory system: developmental aspects and their relevance to aersol therapy. In: Bisgaard H, O’Callaghan C, Smaldone GC, editors. Drug Delivery to the Lung. Marcel Dekker: New York, NY, 2002, pp 47–104.

Kosch PC, Stark AR. Dynamic maintenance of end-expiratory lung volume in full-term infants. J Appl Physiol Respir Environ Exerc Physiol. 1984;57:1126–33.

PubMed  CAS  Google Scholar 

Hislop AA, Haworth SG. Airway size and structure in the normal fetal and infant lung and the effect of premature delivery and artificial ventilation. Am Rev Respir Dis. 1989;140:1717–26.

Article  PubMed  CAS  Google Scholar 

Rodenstein DO, Perlmutter N, Stanescu DC. Infants are not obligatory nasal breathers. Am Rev Respir Dis. 1985;131:343–7.

PubMed  CAS  Google Scholar 

Chua HL, Collis GG, Newbury AM, Chan K, Bower GD, Sly PD, et al. The influence of age on aerosol deposition in children with cystic fibrosis. Eur Respir J. 1994;7:2185–91.

Article  PubMed  CAS  Google Scholar 

Wolfsdorf J, Swift DL, Avery ME. Mist therapy reconsidered; an evaluation of the respiratory deposition of labelled water aerosols produced by jet and ultrasonic nebulizers. Pediatrics. 1969;43:799–808.

Article  PubMed  CAS  Google Scholar 

Salmon B, Wilson NM, Silverman M. How much aerosol reaches the lungs of wheezy infants and toddlers? Arch Dis Child. 1990;65:401–3.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bianco F, Salomone F, Milesi I, Murgia X, Bonelli S, Pasini E, et al. Aerosol drug delivery to spontaneously-breathing preterm neonates: lessons learned. Respir Res. 2021;22:71.

Article  PubMed  PubMed Central  Google Scholar 

Numa AH, Newth CJ. Anatomic dead space in infants and children. J Appl Physiol. 1996;80:1485–9.

Article  PubMed  CAS  Google Scholar 

Diot P, Palmer LB, Smaldone A, DeCelie-Germana J, Grimson R, Smaldone GC. RhDNase I aerosol deposition and related factors in cystic fibrosis. Am J Respir Crit Care Med. 1997;156:1662–8.

Article  PubMed  CAS  Google Scholar 

Collis GG, Cole CH, Le Souef PN. Dilution of nebulised aerosols by air entrainment in children. Lancet. 1990;336:341–3.

Article  PubMed  CAS  Google Scholar 

Abman SH, Collaco JM, Shepherd EG, Keszler M, Cuevas-Guaman M, Welty SE, et al. Interdisciplinary Care of Children with Severe Bronchopulmonary Dysplasia. J Pediatr. 2017;181:12–28.e11.

Article  PubMed  Google Scholar 

Baker CD. Long-term ventilation for children with chronic lung disease of infancy. Curr Opin Pediatr. 2019;31:357–66.

Article  PubMed  Google Scholar 

Hysinger EB. Central airway issues in bronchopulmonary dysplasia. Pediatr Pulmonol. 2021;56:3518–26.

Article  PubMed  PubMed Central  Google Scholar 

Gunatilaka CC, McKenzie C, Hysinger EB, Xiao Q, Higano NS, Woods JC, et al. Tracheomalacia Reduces Aerosolized Drug Delivery to the Lung. J Aerosol Med Pulm Drug Deliv. 2024;37:19–29.

Article  PubMed  Google Scholar 

Terry PB, Traystman RJ. The Clinical Significance of Collateral Ventilation. Ann Am Thorac Soc. 2016;13:2251–7.

Article  PubMed  PubMed Central  Google Scholar 

Di Cicco M, Kantar A, Masini B, Nuzzi G, Ragazzo V, Peroni D. Structural and functional development in airways throughout childhood: Children are not small adults. Pediatr Pulmonol. 2021;56:240–51.

Article  PubMed  Google Scholar 

Davies H, Kitchman R, Gordon I, Helms P. Regional ventilation in infancy. Reversal of adult pattern. N. Engl J Med. 1985;313:1626–8.

Article  PubMed  CAS  Google Scholar 

Davies H, Helms P, Gordon I. Effect of posture on regional ventilation in children. Pediatr Pulmonol. 1992;12:227–32.

Article  PubMed  CAS  Google Scholar 

West JB, Luks AM. West’s Respiratory Physiology. 10th edn. Philadelphia, PA: Wolters Kluwer; 2016.

Google Scholar 

Rubin BK. Taxonomy of Mucoactive Medications. In: Rubin BK, van der Schans CP, editors. Therapy for Mucus-Clearance Disorders. Marcel Dekker: New York, NY, 2004, pp 129–45.

Rubin BK. The pharmacologic approach to airway clearance: mucoactive agents. Paediatr Respir Rev. 2006;7:S215–9.

Article  PubMed  Google Scholar 

Rubin BK. Mucolytics, expectorants, and mucokinetic medications. Respir Care. 2007;52:859–65.

PubMed  Google Scholar 

Lieberman J. Dornase aerosol effect on sputum viscosity in cases of cystic fibrosis. JAMA. 1968;205:312–3.

Article  PubMed  CAS  Google Scholar 

O’Donnell AE, Barker AF, Ilowite JS, Fick RB. Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group. Chest. 1998;113:1329–34.

Article  PubMed  Google Scholar 

Reiter PD, Townsend SF, Velasquez R. Dornase alfa in premature infants with severe respiratory distress and early bronchopulmonary dysplasia. J Perinatol. 2000;20:530–4.

Article  PubMed  CAS  Google Scholar 

El Hassan NO, Chess PR, Huysman MW, Merkus PJ, de Jongste JC. Rescue use of DNase in critical lung atelectasis and mucus retention in premature neonates. Pediatrics. 2001;108:468–70.

Article  PubMed  CAS  Google Scholar 

MacKinnon R, Wheeler KI, Sokol J. Endotracheal DNase for atelectasis in ventilated neonates. J Perinatol. 2011;31:799–801.

Article 

留言 (0)

沒有登入
gif